Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens

Molecular BioSystems

Volumn 8, Issue 12, 2012, Pages 3166-3177

  Galdiero, Stefania ^a   Vitiello, Mariateresa ^b   Finamore, Emiliana ^b   Mansi, Rosalba ^a   Galdiero, Marilena ^b   Morelli, Giancarlo ^a   Tesauro, Diego ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BACTERIAL ANTIGEN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYTOKINE; ENZYME INHIBITOR; EPITOPE; FLAVONOID; GLYCOPROTEIN B, HUMAN HERPESVIRUS 1; GLYCOPROTEIN D, HUMAN HERPESVIRUS 1; IMIDAZOLE DERIVATIVE; L JNKI 1; L-JNKI-1; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PYRIDINE DERIVATIVE; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNIZATION; IMMUNOLOGY; LIPID METABOLISM; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, BACTERIAL; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL LINE, TUMOR; CYTOKINES; ENZYME INHIBITORS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLAVONOIDS; HERPESVIRUS 1, HUMAN; HUMANS; IMIDAZOLES; IMMUNIZATION; LIPID METABOLISM; LIPIDS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; PEPTIDES; PYRIDINES; VIRAL ENVELOPE PROTEINS;

EID: 84868101078     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb25064k     Document Type: Article

References (55)

1. R. Arnon Synthetic peptides as the basis for vaccine design Mol. Immunol. 1991 28 209 215
2. L. BenMohamed S. L. Wechsler A. B. Nesburn Lipopeptide vaccines-yesterday, today, and tomorrow Lancet Infect. Dis. 2002 2 425 431
3. J. A. Berzofsky J. D. Ahlers I. M. Belyakov Strategies for designing and optimizing new generation vaccines Nat. Rev. Immunol. 2002 3 209 219
4. M. Singhand D. T. O'Hagan Recent advances in vaccine adjuvants Pharm. Res. 2002 19 715 728 (Pubitemid 34686729)
5. S. L. Elliott S. Pye T. Le L. Mateo J. Cox L. Macdonald A. A. Scalzo C. A. Forbesand A. Suhrbier Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems Vaccine 1999 17 2009 2019 (Pubitemid 29172372)
6. R. K. Gupta G. R. Siber Adjuvants for human vaccines-current status, problems and future prospects Vaccine 1995 13 1263 1276
7. I. Toth M. Danton N. Flinnand W. A. Gibbons A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids Tetrahedron Lett. 1993 34 3925 3928
8. P. M. Moyle I. Toth Self-adjuvanting lipopeptide vaccines Curr. Med. Chem. 2008 15 506
9. C. Olive I. Tothand D. J. Jackson Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies Mini-Rev. Med. Chem. 2001 1 429 438
10. C. Olive M. Batzloff A. Horváth T. Clair P. Yarwood I. Toth M. F. Good Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct Indian J. Med. Res. 2004 119 88 94 (Pubitemid 39004454)
11. K. Deres H. Schild K. H. Wiesmüller G. Jung H. G. Rammensee In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopepide vaccine Nature 1989 342 561 564 (Pubitemid 20005823)
12. A. Mora J. Tam Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations J. Immunol. 1998 161 3616 3623
13. B. Nardelli B. Paul H. P. James J. Tam Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses Vaccine 1994 12 1335 1339 (Pubitemid 24325734)
14. W. Zeng D. C. Jackson J. Murray K. Rose L. E. Brown Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens Vaccine 2000 18 1031 1039
15. L. BenMohamed H. Gras-Masse A. Tartar P. Daubersies K. Brahimi M. Bossus A. Thomas P. Druilhe Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees Eur. J. Immunol. 1997 27 1242 1253 (Pubitemid 27197230)
16. G. Zong I. Toth R. Reid R. C. Brunham Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis J. Immunol. 1993 151 3728 3736 (Pubitemid 23282685)
17. I. Toth, N. Flinn, W. A. Gibbons, M. Good, W. Hayman and F. Brown, Immunological evaluation of the lipid-core-peptide (LCP) adjuvant/carrier system, in Peptides Chemistry, Structure and Biology, ed., T. P. Pravin, R. Kaumaya, and, S. Hodges, Mayflower Scientific Ltd., Kingswinford, 1996, pp. 810-811
18. C. Olive M. R. Batzloff A. Horváth A. Wong T. Clair P. Yarwood I. Toth M. F. Good A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies Infect. Immun. 2002 70 2734 2738 (Pubitemid 34408426)
19. C. Olive M. Batzloff A. Horváth T. Clair P. Yarwood I. Toth M. F. Good Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens Infect. Immun. 2003 71 373 2383
20. C. Olive K. Hsien A. Horváth T. Clair P. Yarwood I. Toth M. F. Good Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides Vaccine 2005 23 298 2303
21. C. Olive M. F. Ho J. Dyer D. Lincoln N. Barozzi I. Toth M. F. Good Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus J. Infect. Dis. 2006 193 1666 1676 (Pubitemid 43839471)
22. W. A. Hayman I. Toth N. Flinn M. Scanlon M. F. Good Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology Immunol. Cell Biol. 2002 80 178 187 (Pubitemid 34298091)
23. E. de Oliveira J. Villen E. Giralt D. Andreu Synthetic Approaches to Multivalent Lipopeptide Dendrimers Containing Cyclic Disulfide Epitopes of Foot-and-Mouth Disease Virus Bioconjugate Chem. 2003 14 144 152 (Pubitemid 36169027)
24. J. Tam Y. Lu A. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T-and B-cell epitopes Proc. Natl. Acad. Sci. U. S. A. 1989 86 9084 9088 (Pubitemid 20010369)
25. Y. Haro S. Perez M. Garcia W. C. Chan G. Ercilla Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design FEBS Lett. 2003 540 1-3 133 140 (Pubitemid 36398045)
26. C. J. Fitzmaurice L. E. Brown T. L. McInerney D. C. Jackson The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants Vaccine 1996 14 553 560 (Pubitemid 26173756)
27. S. Depil O. Moralès F. A. Castelli N. Delhem V. François B. Georges F. Dufossé F. Morschhauser J. Hammer B. Maillère C. Auriault V. Pancré Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies J. Immunother. 2007 30 215 226 (Pubitemid 46667801)
28. L. Shen R. Schroers J. Hammer X. F. Huang S. Y. Chen Identification of a MHC class-II restricted epitope in carcinoembryonic antigen Cancer Immunol. Immunother. 2004 53 391 403 (Pubitemid 38657252)
29. J. Hammer T. Sturniolo F. Sinigaglia HLA class II peptide binding specificity and autoimmunity Adv. Immunol. 1997 66 67 100
30. W. W. Kwok J. A. Gebe A. Liu S. Agar N. Ptacek J. Hammer D. M. Koelle G. T. Nepom Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Trends Immunol. 2001 22 583 588
31. L. BenMohamed G. Bertrand C. D. McNamara H. Gras-Masse J. Hammer S. L. Wechsler A. B. Nesburn Identification of Novel Immunodominant CD+ Th1-Type T-Cell Peptide Epitopes from Herpes Simpex Virus Glycoprotein D That Confer Protective Immunity J. Virol. 2003 77 9463 9473 (Pubitemid 37011042)
32. B. Rost C. Sander Prediction of protein secondary structure at better than 70% accuracy J. Mol. Biol. 1993 232 584 589
33. P. Prevelige and G. D. Fasman, Prediction of Protein Structure and Principles of Protein Conformation, Plenum Press, New York, 1990
34. S. Smith N. J. Robinson Age-Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review J. Infect. Dis. 2002 186 Suppl 1 3 28
35. D. I. Bernstein L. R. Stanberry Herpes simplex virus vaccines Vaccine 1999 171 1681 1689 (Pubitemid 29138901)
36. M. Aymard Current epidemiology of herpes Pathol. Biol. 2002 50 425 435
37. R. J. Whitley D. W. Kimberlin B. Roizman Herpes simplex viruses Clin. Infect. Dis. 1998 26 541 553
38. S. S. Cush K. M. Anderson D. H. Ravneberg J. L. Weslow-Schmidt E. Flano Memory Generation and Maintenance of CD8+ T Cell Function during Viral Persistence J. Immunol. 2007 179 141 153 (Pubitemid 46986528)
39. A. A. Chentoufi X. Zhang K. Lamberth G. Dasgupta I. Bettahi A. Nguyen M. Wu X. Zhu A. Mohebbi S. Buus S. L. Wechsler A. B. Nesburn L. BenMohamed HLA-A *0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D J. Immunol. 2008 180 426 437
40. P. Y. Chou G. D. Fasman Prediction of protein conformation Biochemistry 1974 13 222 245
41. P. Y. Chou G. D. Fasman Conformational parameters for amino acids in helical, b-sheet and random coil regions calculated from proteins Biochemistry 1974 13 211 222
42. M. Galdiero A. Tortora N. Damiano M. Vitiello A. Longanella E. Galdiero Induction of cytokine mRNA expression in U937 cells by Salmonella typhimurium porins is regulated by different phosphorylation pathways Med. Microbiol. Immunol. 2005 194 13 23 (Pubitemid 40064625)
43. M. F. Taylor J. D. Paulauskis D. D. Weller L. Kobzik In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA J. Biol. Chem. 1996 271 29 17445 17452 (Pubitemid 26244310)
44. A. Cuenda J. Rouse Y. N. Doza R. Meier P. Cohen T. F. Gallagher P. R. Yang J. C. Lee SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 FEBS Lett. 1995 364 229 233
45. D. R. Alessi A. Cuenda P. Cohen D. T. Dudley A. R. Saltiel PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo J. Biol. Chem. 1995 270 27489 27494
46. C. Bonny A. Oberson S. Negri C. Sauser D. F. Schorderet Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death Diabetes 2001 50 77 82 (Pubitemid 32047984)
47. E. T. Yin C. Galanos S. Kinsky R. A. Bradshaw S. Wessler O. Luderity M. E. Sarmiento Picogram sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram negative bacteria Biochim. Biophys. Acta 1972 261 284 289
48. I. Bettahi A. B. Nesburn S. Yoon X. Zhang A. Mohebbi V. Sue A. Vanderberg S. L. Wechslerand L. BenMohamed Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines Invest. Ophthalmol. Visual Sci. 2007 48 4643 4653 (Pubitemid 351260982)
49. A. B. Nesburn T. V. Ramos X. Zhu H. Asgarzadeh V. Nguyen L. BenMohamed Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant Vaccine 2005 23 873 883 (Pubitemid 39643174)
50. W. A. Gibbons R. A. Hughes M. Charalambous M. Christodoulou A. Szeto A. E. Aulabough P. Mascagni I. Toth Lipidic Peptides I. Synthesis resolution and structural elucidation of fatty amino acids and their homo- and hetero-oligomers Liebigs Ann. Chem. 1990 1175 1183
51. M. Krishna H. Narang The complexity of mitogen-activated protein kinases (MAPKs) made simple Cell. Mol. Life Sci. 2008 65 3525 3544
52. J. Garcia B. Lemercier S. Roman-Roman G. Rawadi A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways J. Biol. Chem. 1998 273 34391 34398 (Pubitemid 29008917)
53. S. R. Paludan J. Melchjorsen L. Malmgaard S. C. Mogensen Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: comparison between resistant and susceptible mouse strains Eur. Cytokine Network 2002 13 306 316 (Pubitemid 35015068)
54. J. Kelly M. H. Beddall D. Yu S. R. Iyer J. W. Marsh Y. Wu Human macrophages support persistent transcription from unintegrated HIV-1 DNA Virology 2008 372 300 312 (Pubitemid 351273752)
55. W. Wang L. Ye L. Ye B. Li B. Gao Y. Zeng L. Kong X. Fang H. Zheng Z. Wu Y. She Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway Virus Res. 2007 128 1 8 (Pubitemid 47242878)